Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04974697 · ClinicalTrials.gov registry record · NA
Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses
A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 8
- Study locations
NCT04974697: Completed NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
NCT04974697 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 95 participants, below the 135-participant average among 20 other Visual Acuity trials with a reported enrollment target (30% lower). The trial reports 8 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04974697, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 8
- Study locations
Study Summary
The study is a bilateral, single-masked, single-arm, 4-visit dispensing study. There will be one study treatment, with the subject being dispensed lenses for 6 to 8 days, then lens power will be optimized (if necessary) and dispensed for a further 2 weeks to assess the clinical performance of investigational multifocal toric contact lenses.
Primary Outcome
Overall vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20),where higher scores indicate a more favorable/posi
Conditions Studied
Interventions
- DEVICE JJVC Investigational Multifocal Toric Contact Lens
Study Locations (8)
Florida
- Stam & Associates Eye Care - Jacksonville
- VRC-West - Jacksonville
- Maitland Vision Center - Maitland
New York
- Eye Associates of New York - New York
- Sacco Eye Group - Vestal
Kansas
- Kannarr Eye Care - Pittsburg
Michigan
- Birmingham Vision Care - Bloomfield Township
Texas
- Tyler Eye Associates - Tyler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2021-07-19 |
| Est. Completion | 2021-10-29 |
| Phase | NA |
What the finished NCT04974697 record still lists
NCT04974697 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 135-participant average among 20 other Visual Acuity trials with a reported enrollment target (30% lower).
The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 1 intervention - of which JJVC Investigational Multifocal Toric Contact Lens is the first listed.
NCT04974697 lists 8 locations in 5 states (Florida, New York, Kansas).
Frequently Asked Questions
What is clinical trial NCT04974697 about?
NCT04974697 is a clinical study titled "Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses". The study is a bilateral, single-masked, single-arm, 4-visit dispensing study. There will be one study treatment, with the subject being dispensed lenses for 6 to 8 days, then lens power will be optimized (if necessary) and dispensed for a further 2 weeks to assess the clinical performance of invest...
What is the current status of trial NCT04974697?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2021-07-19. Estimated completion is 2021-10-29.
What conditions does trial NCT04974697 study?
This clinical trial studies the following conditions: Visual Acuity.
What interventions are being tested in trial NCT04974697?
The interventions under investigation include: JJVC Investigational Multifocal Toric Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT04974697?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04974697 being conducted?
This trial has 8 study locations across Florida, Kansas, Michigan, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Visual Acuity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04974697's enrollment target sits among peer trials
95 10th of 20 higher than 10 of 20 other Visual Acuity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Visual Acuity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Effect of Scatter on Visual Performance
RECRUITING · NA
-
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2
COMPLETED · NA
-
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
COMPLETED · NA
-
Clinical Evaluation of Approved Contact Lenses
COMPLETED · NA
-
Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
COMPLETED · NA
-
Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic Population
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI